We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.95B
AUM Growth
-$1.04B
Cap. Flow
-$663M
Cap. Flow %
-11.14%
Top 10 Hldgs %
61.43%
Holding
140
New
12
Increased
47
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$26.5M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.49M
3
CI icon
Cigna
CI
+$6.85M
4
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.9M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$4.58M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$123M
2
HDB icon
HDFC Bank
HDB
+$78.3M
3
V icon
Visa
V
+$71.4M
4
GILD icon
Gilead Sciences
GILD
+$42M
5
DIS icon
Walt Disney
DIS
+$38.2M

Sector Composition

Rank Sector Weight
1 Financials 33.21%
2 Healthcare 25.04%
3 Communication Services 16.03%
4 Consumer Discretionary 12.69%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$644B
$23.5M 0.4%
251,751
-71,700
-22% -$6.94M
CI icon
27
Cigna
CI
$78.8B
$23.5M 0.39%
173,800
+47,200
+37% +$6.85M
CEMP
28
DELISTED
Cempra, Inc.
CEMP
$21.4M 0.36%
766,930
+12,630
+2% +$469K
EGRX
29
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$20.3M 0.34%
273,907
-5,500
-2% -$458K
TEVA icon
30
Teva Pharmaceuticals
TEVA
$39.1B
$19.8M 0.33%
351,500
+115,500
+49% +$7.49M
CNC icon
31
Centene
CNC
$30.8B
$18.4M 0.31%
679,400
-13,800
-2% -$462K
COR icon
32
Cencora
COR
$62.1B
$17.6M 0.3%
184,900
-6,300
-3% -$661K
PFE icon
33
Pfizer
PFE
$144B
$17.1M 0.29%
573,286
-16,232
-3% -$520K
ESRX
34
DELISTED
Express Scripts Holding Company
ESRX
$16.9M 0.28%
208,201
-5,500
-3% -$479K
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$16.1B
$14M 0.24%
105,327
+3,540
+3% +$610K
HCA icon
36
HCA Healthcare
HCA
$92B
$13.9M 0.23%
179,075
+29,800
+20% +$2.64M
COO icon
37
Cooper Companies
COO
$14.2B
$13.4M 0.22%
358,800
-8,400
-2% -$348K
ABBV icon
38
AbbVie
ABBV
$470B
$12.4M 0.21%
227,500
-32,500
-13% -$2.12M
AIRM
39
DELISTED
Air Methods Corp
AIRM
$10.2M 0.17%
299,736
-25,400
-8% -$981K
SHPG
40
DELISTED
Shire pic
SHPG
$10.1M 0.17%
49,274
+3,065
+7% +$729K
MRK icon
41
Merck
MRK
$324B
$10.1M 0.17%
214,208
-171,662
-44% -$9.12M
NKE icon
42
Nike
NKE
$63.2B
$9.62M 0.16%
156,480
+4,000
+3% +$226K
BABA icon
43
Alibaba
BABA
$276B
$8.61M 0.14%
145,920
+19,600
+16% +$1.43M
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
$8.48M 0.14%
221,950
-52,050
-19% -$2.57M
BIDU icon
45
Baidu
BIDU
$35.6B
$7.98M 0.13%
58,065
+7,440
+15% +$1.23M
BMRN icon
46
BioMarin Pharmaceuticals
BMRN
$11.9B
$7.74M 0.13%
73,475
-1,410
-2% -$188K
DVA icon
47
DaVita
DVA
$15.5B
$6.92M 0.12%
95,691
-2,800
-3% -$217K
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
$6.45M 0.11%
41,211
-850
-2% -$155K
CPHD
49
DELISTED
Cepheid Inc
CPHD
$5.21M 0.09%
115,220
+25,220
+28% +$1.35M
PODD icon
50
Insulet
PODD
$11.7B
$5.13M 0.09%
198,000
-15,000
-7% -$455K
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q3 2015 Portfolio in Review

As of Q3 2015, C WorldWide Group held 140 positions worth $5.95B, down 15% from $6.99B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

C WorldWide Group withdrew a net $663M in Q3 2015, closing 9 positions and reducing 48 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.68M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in Ultragenyx Pharmaceutical worth $3.85M.

  • C WorldWide Group's largest Q3 2015 buy was Ultragenyx Pharmaceutical: 40,000 shares worth $3.85M.
  • C WorldWide Group added most to McKesson in Q3 2015, an estimated $26.5M increase.
  • C WorldWide Group's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $123M.
  • C WorldWide Group fully exited Zimmer Biomet in Q3 2015, selling an estimated $8.68M.
  • C WorldWide Group's ten largest holdings make up 61% of its $5.95B portfolio in Q3 2015.
  • C WorldWide Group opened 12 new positions and closed 9 in Q3 2015.
  • C WorldWide Group's portfolio value fell 15% quarter-over-quarter to $5.95B.

Based on C WorldWide Group's 13F filing for Q3 2015, filed 12 Nov 2015.